Table I.
Patient Disposition for the Efficacy Cohort
| Algorithm Step | n | % | Mean SeSBP/SeDBP at Study Baseline (mm Hg) |
|---|---|---|---|
| Olmesartan medoxomil 20 mg/d | 197 | 100 | 161.2/96.6 |
| Olmesartan medoxomil 40 mg/d | 156 | 79.2 | 163.3/97.2 |
| Olmesartan medoxomil 40 mg/d + HCTZ 12.5 mg/d | 123 | 62.4 | 164.6/97.6 |
| Olmesartan medoxomil 40 mg/d + HCTZ 25 mg/d | 78 | 39.6 | 166.6/98.2 |
| Olmesartan medoxomil 40 mg/d + HCTZ 25 mg/d + amlodipine besylate 5 mg/d | 49 | 24.9 | 168.1/98.5 |
| Olmesartan medoxomil 40 mg/d + HCTZ 25 mg/d + amlodipine besylate 10 mg/d | 22 | 11.2 | 170.7/100.9 |
| SeSBP=seated systolic blood pressure; SeDBP=seated diastolic blood pressure; HCTZ=hydrochlorothiazide | |||